Bill J. Gurley

5.9k total citations · 1 hit paper
110 papers, 4.2k citations indexed

About

Bill J. Gurley is a scholar working on Pharmacology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Bill J. Gurley has authored 110 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pharmacology, 34 papers in Pharmacology and 31 papers in Complementary and alternative medicine. Recurrent topics in Bill J. Gurley's work include Pharmacogenetics and Drug Metabolism (29 papers), Complementary and Alternative Medicine Studies (24 papers) and Pharmacological Effects of Natural Compounds (20 papers). Bill J. Gurley is often cited by papers focused on Pharmacogenetics and Drug Metabolism (29 papers), Complementary and Alternative Medicine Studies (24 papers) and Pharmacological Effects of Natural Compounds (20 papers). Bill J. Gurley collaborates with scholars based in United States, United Kingdom and Italy. Bill J. Gurley's co-authors include Martha A. Hubbard, Stephanie F. Gardner, David Williams, Gary W. Barone, Mansoor A. Khan, Indra K. Reddy, W. Brooks Gentry, Sameh R. Abul‐Ezz, Yanyan Cui and C.Y.W. ANG and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, International Journal of Molecular Sciences and Journal of Nutrition.

In The Last Decade

Bill J. Gurley

105 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment

2001 508 citations Bill J. Gurley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bill J. Gurley United States	30	1.5k	1.2k	1.2k	706	656	110	4.2k
Eli Chan Singapore	32	1.5k 1.0×	609 0.5×	826 0.7×	1.2k 1.7×	424 0.6×	76	3.8k
Abul Kalam Najmi India	37	693 0.5×	1.5k 1.2×	576 0.5×	1.2k 1.6×	493 0.8×	225	5.3k
Yu‐Chi Hou Taiwan	36	946 0.6×	456 0.4×	832 0.7×	1.2k 1.6×	862 1.3×	115	3.3k
Jianguo Sun China	40	1.1k 0.7×	711 0.6×	590 0.5×	2.5k 3.5×	411 0.6×	181	5.7k
Hye Suk Lee South Korea	39	935 0.6×	304 0.3×	676 0.6×	2.4k 3.4×	397 0.6×	254	5.1k
Manfred Schubert‐Zsilavecz Germany	43	742 0.5×	620 0.5×	1.6k 1.4×	3.1k 4.3×	865 1.3×	235	6.2k
Sameer N. Goyal India	35	522 0.3×	875 0.7×	584 0.5×	1.3k 1.8×	498 0.8×	127	4.1k
Pei-Dawn Lee Chao Taiwan	28	747 0.5×	396 0.3×	670 0.6×	958 1.4×	764 1.2×	65	2.6k
Baochang Cai China	38	1.6k 1.1×	1.4k 1.1×	843 0.7×	2.8k 3.9×	1.3k 2.0×	357	5.8k
Paolo Morazzoni Italy	45	719 0.5×	610 0.5×	650 0.6×	1.7k 2.4×	1.2k 1.9×	138	5.8k

Countries citing papers authored by Bill J. Gurley

Since Specialization

Citations

This map shows the geographic impact of Bill J. Gurley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bill J. Gurley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bill J. Gurley more than expected).

Fields of papers citing papers by Bill J. Gurley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bill J. Gurley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bill J. Gurley. The network helps show where Bill J. Gurley may publish in the future.

Co-authorship network of co-authors of Bill J. Gurley

This figure shows the co-authorship network connecting the top 25 collaborators of Bill J. Gurley. A scholar is included among the top collaborators of Bill J. Gurley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bill J. Gurley. Bill J. Gurley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chikowe, Ibrahim, Nozgechi Phiri, Malango Msukwa, et al.. (2025). An exploratory evaluation of the interaction risk between herbal products and pharmaceutical medicines used concurrently for disease management in Blantyre, Malawi. Pharmaceutical Biology. 63(1). 877–895.

Husain, Islam, Olivia R. Dale, Kumar Katragunta, et al.. (2024). Interaction of Phyllanthus amarus extract and its lignans with human xenobiotic receptors, drug metabolizing enzymes and drug transporters. Journal of Ethnopharmacology. 339. 119142–119142. 1 indexed citations

Gurley, Bill J.. (2024). Clinically Relevant Herb–Drug Interactions: A 30-Year Historical Assessment. Journal of Dietary Supplements. 22(1). 78–104. 5 indexed citations

Husain, Islam, Bill J. Gurley, Yan‐Hong Wang, et al.. (2024). Evaluation of bioaccessibility, metabolic clearance and interaction with xenobiotic receptors (PXR and AhR) of cinnamaldehyde. Food Chemistry Molecular Sciences. 10. 100237–100237. 2 indexed citations

Wang, Yan‐Hong, Goutam Mondal, Washim Khan, Bill J. Gurley, & Charles R. Yates. (2023). Development of a liquid chromatography-tandem mass spectrometry (LC–MS/MS) method for characterizing pomegranate extract pharmacokinetics in humans. Journal of Pharmaceutical and Biomedical Analysis. 233. 115477–115477. 5 indexed citations

Husain, Islam, Olivia R. Dale, Bill J. Gurley, et al.. (2022). Screening of medicinal plants for possible herb-drug interactions through modulating nuclear receptors, drug-metabolizing enzymes and transporters. Journal of Ethnopharmacology. 301. 115822–115822. 29 indexed citations

Roe, Amy L., Mary F. Paine, Bill J. Gurley, et al.. (2016). Assessing Natural Product–Drug Interactions: An End-to-End Safety Framework. Regulatory Toxicology and Pharmacology. 76. 1–6. 28 indexed citations

Gupta, Prem K., Gary W. Barone, Bill J. Gurley, E. Kim Fifer, & Howard P. Hendrickson. (2015). Hydrastine Pharmacokinetics and Metabolism after a Single Oral Dose of Goldenseal (Hydrastis canadensis) to Humans. Drug Metabolism and Disposition. 43(4). 534–552. 17 indexed citations

Hammond, Drayton A., et al.. (2015). Ventricular Tachycardia Precipitated by the Use of the Diet Supplement Hydroxycut Gummies. Hospital Pharmacy. 50(7). 615–618. 5 indexed citations

10.

Wang, Xinwen, et al.. (2015). An ex vivo approach to botanical–drug interactions: A proof of concept study. Journal of Ethnopharmacology. 163. 149–156. 9 indexed citations

11.

Gurley, Bill J., et al.. (2014). Multi-ingredient, Caffeine-containing Dietary Supplements: History, Safety, and Efficacy. Clinical Therapeutics. 37(2). 275–301. 70 indexed citations

12.

Gurley, Bill J.. (2011). Emerging Technologies for Improving Phytochemical Bioavailability: Benefits and Risks. Clinical Pharmacology & Therapeutics. 89(6). 915–919. 23 indexed citations

13.

Gurley, Bill J.. (2009). Clinical Pharmacology and Dietary Supplements: An Evolving Relationship. Clinical Pharmacology & Therapeutics. 87(2). 235–238. 14 indexed citations

14.

Gurley, Bill J., Ashley Swain, Martha A. Hubbard, et al.. (2008). Clinical assessment of CYP2D6‐mediated herb–drug interactions in humans: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, andEchinacea. Molecular Nutrition & Food Research. 52(7). 755–763. 121 indexed citations

15.

Gurley, Bill J., Martha A. Hubbard, David Williams, et al.. (2006). Assessing the Clinical Significance of Botanical Supplementation on Human Cytochrome P450 3A Activity: Comparison of a Milk Thistle and Black Cohosh Product to Rifampin and Clarithromycin. The Journal of Clinical Pharmacology. 46(2). 201–213. 88 indexed citations

16.

Gurley, Bill J., Stephen D. Gardner, Martha A. Hubbard, et al.. (2005). In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clinical Pharmacology & Therapeutics. 77(5). 415–426. 201 indexed citations

17.

Gurley, Bill J., Stephen D. Gardner, Martha A. Hubbard, et al.. (2004). In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: , , milk thistle, and saw palmetto. Clinical Pharmacology & Therapeutics. 76(5). 428–440. 150 indexed citations

18.

Barone, Gary W., et al.. (2001). St John's wort: a hidden risk for transplant patients. Progress in Transplantation. 11(2). 116–120. 36 indexed citations

19.

Barone, Gary W., et al.. (2001). Authors' Reply. Annals of Pharmacotherapy. 35(1). 124–125. 2 indexed citations

20.

Penzak, Scott, et al.. (1999). Grapefruit Juice Decreases the Systemic Availability of Itraconazole Capsules in Healthy Volunteers. Therapeutic Drug Monitoring. 21(3). 304–304. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact